Rapid Flow Cytometric Data Analysis Solution

The contract involves acquiring FCS Express 7 IVD, a sophisticated flow cytometry data analysis software developed and exclusively owned by De Novo Software. This software is designed to significantly streamline the analysis process of flow cytometric data, which traditionally requires extensive technologist hours, by offering an intuitive, user-friendly interface modeled after Microsoft Office. It supports comprehensive analysis features such as multi-page viewing, high-resolution graphics export, flexible gating, and advanced statistical tools, making it suitable for both clinical and research settings. The software's capabilities extend to analyzing data from all major cytometry vendors, supporting various FCS file versions, and integrating with laboratory information systems, all while ensuring compliance with regulatory standards including FDA listing, 21 CFR Part 11, and Section 508 accessibility. The procurement is justified as a sole source due to the software’s unique features, FDA listing as a medical device, and its compliance with stringent quality and security standards. The contract size is estimated between 50,000 and 150,000 dollars, with the University of Mississippi Medical Center acting as the contracting agency. Key contractual provisions include the implementation of permission rules and authorizations at the layout level to control user actions, full security and audit trail features for regulatory compliance, and availability of validation packages to ensure software integrity. The contract emphasizes the importance of quality control, data security, and collaboration functionalities, making FCS Express 7 IVD an essential tool for efficient, compliant, and high-dimensional flow cytometry data analysis in clinical laboratories.